Regeneron Pharmaceuticals Incorporated
General
Cases6
Challenger50%
Patent Owner50%
NPE50%
--
--
Practice Areas
Biotech
Top Attorneys
Elite Ratings
DCTPTABCAFC
Analytics
Lawyers
Cases
Ratings Trends
Practice Areas
Recent Dockets
Entered | Case | Description |
---|---|---|
11/15/24 | ORDER GRANTING MOTIONS TO WITHDRAW AS COUNSEL (ECF NOS. [394] , [395] ). Signed by Chief District Judge Thomas S. Kleeh on 11/15/2024. Associated Cases: 1:24-md-03103-TSK-JPM et al. (snc) (Entered: 11/15/2024) | |
06/17/24 | SO ORDERED Granting 1098 Joint Stipulation to Substitute Party and Amend Case Caption. Signed by Judge Richard G. Andrews on 6/17/2024. (nms) (Entered: 06/17/2024) | |
08/03/21 | REPORT ON THE DETERMINATION OF AN ACTION Regarding a Patent or Trademark. (Closing) (Attachments: # [1] Order Granting Joint Motion to Dismiss) (gk) (Entered: 08/03/2021) | |
08/03/21 | REPORT ON THE DETERMINATION OF AN ACTION Regarding a Patent or Trademark. (Closing) (Attachments: # 1 Order Granting Joint Motion to Dismiss) (gk) (Entered: 08/03/2021) | |
08/03/21 | ORDER GRANTING JOINT MOTION TO DISMISS by Judge Andre Birotte Jr.: The parties joint motion to dismiss pursuant to Federal Rule of Civil Procedure 4l(a)(2) and (c) 402 is GRANTED. All of Immunexs claims as to Defendants in the action are hereby DISMISSED WITH PREJUDICE. All of Defendants counterclaims in the action are hereby DISMISSED WITHOUT PREJUDICE. As the prevailing party, Defendants shall be entitled to their costs amounting to $39,811.80 to be paid to Defendants within 30 days of the Courts order of dismissal. Each party shall bear its own attorneys fees. ( MD JS-6. Case Terminated ) (gk) (Entered: 08/03/2021) |